MA26768A1 - Combinaison de chimiotherapie - Google Patents
Combinaison de chimiotherapieInfo
- Publication number
- MA26768A1 MA26768A1 MA26275A MA26275A MA26768A1 MA 26768 A1 MA26768 A1 MA 26768A1 MA 26275 A MA26275 A MA 26275A MA 26275 A MA26275 A MA 26275A MA 26768 A1 MA26768 A1 MA 26768A1
- Authority
- MA
- Morocco
- Prior art keywords
- chemotherapy combination
- chemotherapy
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Seasonings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11329198P | 1998-12-22 | 1998-12-22 | |
| US16478899P | 1999-11-10 | 1999-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26768A1 true MA26768A1 (fr) | 2004-12-20 |
Family
ID=26810891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA26275A MA26768A1 (fr) | 1998-12-22 | 2001-07-19 | Combinaison de chimiotherapie |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1140291B1 (fr) |
| JP (1) | JP2002532570A (fr) |
| KR (1) | KR20010099877A (fr) |
| CN (1) | CN1333698A (fr) |
| AP (1) | AP2001002175A0 (fr) |
| AT (1) | ATE310567T1 (fr) |
| AU (1) | AU2203900A (fr) |
| BG (1) | BG105715A (fr) |
| BR (1) | BR9916839A (fr) |
| CA (1) | CA2352326A1 (fr) |
| CZ (1) | CZ20012139A3 (fr) |
| DE (1) | DE69928568T2 (fr) |
| EA (1) | EA200100687A1 (fr) |
| EE (1) | EE200100339A (fr) |
| ES (1) | ES2253928T3 (fr) |
| GE (1) | GEP20043172B (fr) |
| HK (1) | HK1042057A1 (fr) |
| HR (1) | HRP20010473A2 (fr) |
| HU (1) | HUP0104844A3 (fr) |
| ID (1) | ID30250A (fr) |
| IL (1) | IL143939A0 (fr) |
| IS (1) | IS5969A (fr) |
| MA (1) | MA26768A1 (fr) |
| NO (1) | NO20013099L (fr) |
| NZ (1) | NZ512859A (fr) |
| OA (1) | OA11733A (fr) |
| PL (1) | PL348326A1 (fr) |
| SK (1) | SK8712001A3 (fr) |
| TR (1) | TR200101871T2 (fr) |
| WO (1) | WO2000037141A1 (fr) |
| YU (1) | YU45401A (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE05450B1 (et) | 2000-07-19 | 2011-08-15 | Warner-Lambert Company | 4-jodofenlaminobenshdroksaamhapete oksgeenitud estrid, nende kristallvormid ja farmatseutilised kompositsioonid ning kasutamine |
| WO2002017952A2 (fr) | 2000-09-01 | 2002-03-07 | Van Andel Institute | Inhibition de la voie de la proteine mapkkk: une strategie therapeutique selective contre les melanomes |
| EP1377312A4 (fr) * | 2001-03-22 | 2004-10-06 | Andel Inst Van | Facteur letal de l'anthrax inhibant la croissance tumorale et l'angiogenese |
| NZ518726A (en) | 2001-05-09 | 2004-06-25 | Warner Lambert Co | Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
| CZ20022216A3 (cs) * | 2001-07-02 | 2003-05-14 | Warner-Lambert Company | Kombinační chemoterapie |
| BRPI0415018A (pt) * | 2003-10-08 | 2006-11-28 | Teijin Pharma Ltd | métodos para a produção de derivados de aminopirrolidina e de antranilamida, e, composto |
| CA2542210A1 (fr) | 2003-10-21 | 2005-05-06 | Warner-Lambert Company Llc | Forme polymorphe du n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-fluoro-4-iodophenylamino)-benzamide |
| WO2006045514A1 (fr) * | 2004-10-20 | 2006-05-04 | Applied Research Systems Ars Holding N.V. | Derives de 3-arylamino pyridine |
| CN1807413B (zh) * | 2005-09-28 | 2010-05-05 | 中国医学科学院医药生物技术研究所 | 咔唑磺酰胺衍生物及其制备方法 |
| ATE504565T1 (de) | 2005-10-07 | 2011-04-15 | Exelixis Inc | Azetidine als mek-inhibitoren bei der behandlung proliferativer erkrankungen |
| WO2007054556A1 (fr) | 2005-11-11 | 2007-05-18 | Æterna Zentaris Gmbh | Nouvelle pyridopyrazine et son utilisation pour la modulation de kinases |
| EP1790342A1 (fr) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Dérivés de pyridopyrazine et leur utilisation comme modulateurs de transduction de signal |
| US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
| CN101605540A (zh) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | 使用mek抑制剂的方法 |
| EP2370568B1 (fr) | 2008-12-10 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Mutations de mek conférant une résistance aux inhibiteurs de mek |
| CN103002894B (zh) | 2010-02-25 | 2016-04-06 | 达纳－法伯癌症研究所公司 | 对braf抑制剂具有抗性的braf突变 |
| EA030276B1 (ru) | 2010-03-09 | 2018-07-31 | Дана-Фарбер Кэнсер Инститьют, Инк. | Способы идентификации страдающих раком пациентов и лечения рака у пациентов, у которых имеется или развивается резистентность к первой терапии рака |
| CN103301096B (zh) * | 2012-03-14 | 2015-05-06 | 中国中化股份有限公司 | 取代二苯胺类化合物作为制备抗肿瘤药物的应用 |
| WO2013169858A1 (fr) | 2012-05-08 | 2013-11-14 | The Broad Institute, Inc. | Méthodes de diagnostic et de traitement chez des patients ayant ou présentant un risque de développer une résistance à une thérapie anticancéreuse |
| IN2015DN03928A (fr) | 2012-10-12 | 2015-10-02 | Exelixis Inc | |
| JP6465790B2 (ja) * | 2013-02-27 | 2019-02-06 | 第一三共株式会社 | Ｍａｐｋシグナル伝達経路を阻害する化合物に対する応答性を予測する方法 |
| CN105384754B (zh) * | 2014-09-02 | 2018-04-20 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
| CN111909053B (zh) * | 2020-08-06 | 2022-12-06 | 湖北省生物农药工程研究中心 | 基于二芳胺单元的酰胺类衍生物及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112248A0 (en) * | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| WO1997032604A1 (fr) * | 1996-03-07 | 1997-09-12 | Novartis Ag | Combinaisons antiproliferatives contenant des oligonucleotides cibles sur raf et des composes chimiotherapeutiques |
| US6251943B1 (en) * | 1997-02-28 | 2001-06-26 | Warner-Lambert Company | Method of treating or preventing septic shock by administering a MEK inhibitor |
| US7183401B1 (en) * | 1997-03-21 | 2007-02-27 | Board Of Regents, The University Of Texas System | NOEY2 gene compositions and methods of use |
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| US6040321A (en) * | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US5959097A (en) * | 1998-11-20 | 1999-09-28 | Isis Pharmaceuticals, Inc. | Antisense modulation of MEK2 expression |
-
1999
- 1999-12-21 EA EA200100687A patent/EA200100687A1/ru unknown
- 1999-12-21 EE EEP200100339A patent/EE200100339A/xx unknown
- 1999-12-21 AP APAP/P/2001/002175A patent/AP2001002175A0/en unknown
- 1999-12-21 NZ NZ512859A patent/NZ512859A/en unknown
- 1999-12-21 AU AU22039/00A patent/AU2203900A/en not_active Abandoned
- 1999-12-21 EP EP99966523A patent/EP1140291B1/fr not_active Expired - Lifetime
- 1999-12-21 ID IDW00200101616A patent/ID30250A/id unknown
- 1999-12-21 SK SK871-2001A patent/SK8712001A3/sk unknown
- 1999-12-21 DE DE69928568T patent/DE69928568T2/de not_active Expired - Fee Related
- 1999-12-21 OA OA1200100161A patent/OA11733A/en unknown
- 1999-12-21 WO PCT/US1999/030485 patent/WO2000037141A1/fr active IP Right Grant
- 1999-12-21 YU YU45401A patent/YU45401A/sh unknown
- 1999-12-21 TR TR2001/01871T patent/TR200101871T2/xx unknown
- 1999-12-21 BR BR9916839-1A patent/BR9916839A/pt not_active Application Discontinuation
- 1999-12-21 KR KR1020017007874A patent/KR20010099877A/ko not_active Application Discontinuation
- 1999-12-21 GE GEAP19996007A patent/GEP20043172B/en unknown
- 1999-12-21 HU HU0104844A patent/HUP0104844A3/hu unknown
- 1999-12-21 ES ES99966523T patent/ES2253928T3/es not_active Expired - Lifetime
- 1999-12-21 CA CA002352326A patent/CA2352326A1/fr not_active Abandoned
- 1999-12-21 CN CN99815040A patent/CN1333698A/zh active Pending
- 1999-12-21 PL PL99348326A patent/PL348326A1/xx not_active Application Discontinuation
- 1999-12-21 CZ CZ20012139A patent/CZ20012139A3/cs unknown
- 1999-12-21 JP JP2000589248A patent/JP2002532570A/ja active Pending
- 1999-12-21 IL IL14393999A patent/IL143939A0/xx unknown
- 1999-12-21 AT AT99966523T patent/ATE310567T1/de not_active IP Right Cessation
-
2001
- 2001-06-14 IS IS5969A patent/IS5969A/is unknown
- 2001-06-21 HR HR20010473A patent/HRP20010473A2/hr not_active Application Discontinuation
- 2001-06-21 NO NO20013099A patent/NO20013099L/no not_active Application Discontinuation
- 2001-07-18 BG BG105715A patent/BG105715A/xx unknown
- 2001-07-19 MA MA26275A patent/MA26768A1/fr unknown
-
2002
- 2002-05-04 HK HK02103397.1A patent/HK1042057A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26768A1 (fr) | Combinaison de chimiotherapie | |
| NO20005215D0 (no) | Dihydropyrimidiner | |
| NO984956D0 (no) | Brenner | |
| ID26974A (id) | Ketoenol siklik arilfenil-tersubstitusi | |
| DE69917956D1 (de) | Tintenzuführsystemadapter | |
| DE69904211D1 (de) | Polyalkoxylierte naphtopyrans | |
| DE69808145D1 (de) | Tintenbehälternachfüllsystem | |
| DE69901661D1 (de) | Fahrzeugnutzsitz | |
| FI980536A (fi) | Kokoonpanolinja | |
| ID21853A (id) | Popok pasang sekali pakai | |
| NO20025502D0 (no) | Kombinasjons kjemoterapi | |
| DE69902762D1 (de) | Riser-spannanordnung | |
| ID24221A (id) | Tempat patrum | |
| DE69811890D1 (de) | Einzellenkalorimeter | |
| FR2789651B1 (fr) | Combinaison de glisse aquatique | |
| DK1124809T3 (da) | Benzoylpyridaziner | |
| DE59913393D1 (de) | Fadenchangierung | |
| NO20000746D0 (no) | Brenner | |
| DE69929274D1 (de) | Durchflussbegrenzer | |
| ATA179498A (de) | Theodolit | |
| DE69917377D1 (de) | Siphonanordnungen | |
| FR2753608B1 (fr) | Combinaison de maintien | |
| NO20005325D0 (no) | Bjelkelagskonstruksjon | |
| ATA32198A (de) | Beschlag | |
| ATA149998A (de) | Ladenbeschlag |